A business in context

SYRA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-31 · 0001493152-26-041251

  2. 4 · Ownership change

    Report date 2026-08-11 · 0001493152-26-038056

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001493152-26-037197

  4. 8-K · Current report

    Report date 2026-08-11 · 0001493152-26-036995 · Items 2.02,9.01

  5. 8-K · Current report

    Report date 2026-07-23 · 0001493152-26-034407 · Items 5.07

  6. DEF 14A · Proxy statement

    Report date 2026-06-01 · 0001493152-26-026639

  7. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001493152-26-021773

  8. 8-K · Current report

    Report date 2026-05-07 · 0001493152-26-021629 · Items 2.02,9.01

  9. 10-K/A · Annual report

    Report date 2025-12-31 · 0001493152-26-019010

  10. 10-K · Annual report

    Report date 2025-12-31 · 0001493152-26-009909

  11. 8-K · Current report

    Report date 2026-03-12 · 0001493152-26-009799 · Items 2.02,9.01

  12. 4 · Ownership change

    Report date 2026-01-05 · 0001493152-26-004918

  13. 8-K · Current report

    Report date 2025-12-15 · 0001493152-25-028301 · Items 5.02,8.01,9.01

  14. 4 · Ownership change

    Report date 2025-11-21 · 0001493152-25-025041

  15. 4 · Ownership change

    Report date 2025-11-21 · 0001493152-25-025039

  16. 4 · Ownership change

    Report date 2025-11-21 · 0001493152-25-025037

  17. 8-K · Current report

    Report date 2025-11-18 · 0001493152-25-024059 · Items 5.03,9.01

  18. 8-K · Current report

    Report date 2025-11-14 · 0001493152-25-023488 · Items 5.07

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001493152-25-022023

  20. 8-K · Current report

    Report date 2025-11-12 · 0001493152-25-021784 · Items 2.02,9.01

  21. DEF 14A · Proxy statement

    Report date 2025-09-19 · 0001493152-25-014246

  22. 8-K · Current report

    Report date 2025-08-13 · 0001641172-25-024383 · Items 5.02

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001641172-25-023235

  24. 8-K · Current report

    Report date 2025-08-12 · 0001641172-25-023118 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-07-28 · 0001641172-25-021576 · Items 5.02

  26. 8-K · Current report

    Report date 2025-06-13 · 0001641172-25-015349 · Items 5.02

  27. 8-K · Current report

    Report date 2025-05-20 · 0001641172-25-011732 · Items 8.01,9.01

  28. 8-K · Current report

    Report date 2025-05-08 · 0001641172-25-009292 · Items 2.02,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001641172-25-009279

  30. 8-K · Current report

    Report date 2025-04-25 · 0001641172-25-008103 · Items 5.02

  31. 8-K · Current report

    Report date 2025-04-08 · 0001641172-25-003154 · Items 8.01

  32. 8-K · Current report

    Report date 2025-03-11 · 0001493152-25-009882 · Items 2.02,9.01

  33. 10-K · Annual report

    Report date 2024-12-31 · 0001493152-25-009873

  34. 8-K · Current report

    Report date 2025-01-15 · 0001493152-25-002656 · Items 8.01

  35. 4 · Ownership change

    Report date 2025-01-07 · 0001493152-25-001490

  36. 4 · Ownership change

    Report date 2025-01-07 · 0001493152-25-001489

  37. 8-K · Current report

    Report date 2024-11-01 · 0001493152-24-043326 · Items 8.01

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001493152-24-042875

  39. 8-K · Current report

    Report date 2024-10-29 · 0001493152-24-042779 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2024-10-18 · 0001493152-24-041772 · Items 3.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001922335Syra Health Corp

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$7.98M$8.50M
    2023-12-31$5.52M$6.04M
    2022-12-31$5.62M$6.41M

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗